期刊文献+

MRSA对万古霉素、替考拉宁和利奈唑胺体外诱导耐药性比较 被引量:5

Comparison on In-vitro Induction of Resistance in Methicillin-resistance Staphylococcus Aureus to Vancomycin,Teicoplanin and Linezolid
下载PDF
导出
摘要 [目的]通过比较万古霉素、替考拉宁和利奈唑胺体外诱导耐甲氧西林金葡菌(methicillin-resistant Staphylococcus aureus,MRSA)前后的最低抑菌浓度(minimal inhibitory concentration,MIC)变化,探讨此3种抗菌药物在诱导耐药性上有无差别。[方法]琼脂二倍稀释法检测9株MRSA分别对万古霉素、替考拉宁、利奈唑胺的MIC,筛选出2株对3种药物均敏感的MRSA,用上述3种药物分别诱导2株MRSA25代,最后检测诱导后的MRSA菌株对3种药物的MIC,应用统计学软件进行数据分析。[结果]经万古霉素、替考拉宁、利奈唑胺分别诱导25代后的MRSA菌株与各自诱导前比较,万古霉素和利奈唑胺的MIC升高2倍,替考拉宁的MIC升高2.67倍,但各组间MIC变化无差别,均未见耐药株产生;各组对照组的MRSA菌株经无药平皿传代,各药对其MIC无变化。[结论]3种抗菌药物在诱导MRSA耐药上无差别。 [ Objective] The paper aims to explore the difference of vancomycin, teicoplanin and linezolid in the inducing resistance of MRSA by measuring MIC before and after drug inducing. [ Methods] The MIC of Nine MRSA to vancomycin, teicoplanin and linezolid are identified by two - fold agar dilution method, and then two MRSA which are sensitive to the three drugs are found out. The two MRSA are induced separately by vancomycin, teicoplanin and linezolid for 25 genera- tions. At last, the MIC of MRSA which have been induced to vancomycin, teicoplanin and linezolid are identified. The da- ta is analyzed by SPSS 19.0. [ Results] After vancomycin, teicoplanin and linezolid inducing MRSA for 25 generations re- spectively, the MIC of vancomycin and linezolid increased 2 times and teicoplanin increased 2.67 times compared with those before drug induction. However, there was no difference of the change of MIC among the 3 groups. Additionally, no resistant strains were generated. The MIC of 3 drugs to MRSA strains in control groups in drug -free plates did not change after passage. [ Conclusions] The comparison of the three drugs at inducing resistance have no significant difference.
出处 《大连医科大学学报》 CAS 2012年第3期257-261,共5页 Journal of Dalian Medical University
关键词 MRSA 万古霉素 替考拉宁 利奈唑胺 诱导耐药 MRSA vancomycin teicoplanin linezolid inducing resistance
  • 相关文献

参考文献10

  • 1Chambers HF. Methicillin resistance in Staphylococci: mo- lecular and biochemical basis and clinical implications [ J ]. Clin Microbiol Rev, 1997, 4:781 -791.
  • 2Kleinschmidt SL, Munckhof WJ, Nimmo GR. In vitro expo- sure of community - associated methicillin - resistant Staph- ylococcus aureus(MRSA) strains to vancomycin:does van- comycin resistance occur? [ J ]. Antimicrobial Agents,2006, 27 : 168 - 170.
  • 3Nunes APF, Teixeira LM resistance to vancomycln Iorio NLF, et al. Heteogeneous in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains : characterization of glycopeptide susceptibility profiles and cell wall thickening[J]. Antimicrobial Agents, 2006, 27:307-315.
  • 4叶高峰,马兰,魏华,张秀珍,张延霞,许也齐.MRSA对万古霉素和去甲万古霉素体外诱导耐药性研究[J].中华医院感染学杂志,1999,9(4):196-198. 被引量:28
  • 5Wacanakonakom C. In- vitro induction of resistance in Co- aglase- negative Staphylococci to vancomycin and teicopla- nin[ J ]. J Antimicrob chemother, 1988, 22 ( 3 ) : 321 - 324.
  • 6Clinical and Laboratory Standards Institute (CLSI)/NC- CLS). Performance standards for antimlcmbial susceptibili- ty testing: nighteenth informational supplement [ S ]. 2009,M100 - S19.
  • 7Hiramatsu K, Hanki H, Ino T, et al. Methicillin - resistant staphylococcus aureus clinical strain with reduced vancomy- cin susceptibility[ J]. J Antimicrob Chemother, 1997, 40 (1) : 135 -136.
  • 8Hanaki H, Labischinski H, Inaba Y, et al. Increase in glutaminenon- amidated muropeptidas in the peptidoglycan of vancomycin - resistant Staphylococcus aureus strain Mu50 [ J]. Antimicrob Agents Chemother, 1998, 42(3) : 315 - 320.
  • 9王敬华,周惠琴,杨欢,谢小芳,朱雪明,吴伟,许丽君.利奈唑胺对h-VRS体外抗菌活性研究[J].中国抗生素杂志,2009,34(9):570-574. 被引量:6
  • 10Cazzola M. Advances in the research and development of chemotherapeutic agents for respiratory tract bacterial in- fections[J]. Pulm Pharmacol Ther, 2001, 14 (5) : 367 - 381.

二级参考文献22

  • 1马筱玲,王敬华,李华,陈多炎,濮跃晨.异质性万古霉素耐药葡萄球菌分离及生物学特性观察[J].中华微生物学和免疫学杂志,2004,24(7):583-586. 被引量:48
  • 2王敬华,刘励军,姚辉华.异质性耐万古霉素溶血葡萄球菌的抗生素后效应研究[J].中国抗生素杂志,2006,31(9):532-535. 被引量:8
  • 3王敬华,马筱玲,刘励军,姚辉华.异质性万古霉素耐药金黄色葡萄球菌的抗生素后效应[J].江苏医药,2006,32(12):1142-1144. 被引量:1
  • 4李胜利 张婴元 等.30种抗菌药物对临床分离葡萄球菌作用的研究[J].中国抗生素杂志,1997,22(6):450-450.
  • 5Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospital of strains of Staphylocoeeus aureus heterogeneously resistant to vaneomyein [ J ]. Lancet, 1997, 350 (12) : 1670 - 1673.
  • 6GOLDRICK B. First reported case of VRSA in the United States[ J]. Am J Nuts ,2002,102( 11 ) :17.
  • 7Moore M R,Perdreau Remington F, Chambers H F. Vancomycin treatment failure associated with heterogeneous vaneomycin intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis [ J ]. Antimicrob Agents Chemother, 2003, 47 : 1262 - 1266.
  • 8NCCLS performance standards for antimicmial susceptibility testing[ S]. Sixteenth informational supplement, 2006, M100- S16:48.
  • 9Finan J E, Archer G L, Pucci M J, et al. Role of penicillin binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin resistant Staphylococcus aureus [ J ]. Antimicrob Agents Chemother, 2001, 45:3070-3075.
  • 10Fridkin S K. Vancomycin-intennediate and resistant Staphylococcus aureus: what the infectious disease Specialist needs to know[J]. Clin Infect Dis, 2001, 32:108 - 115.

共引文献32

同被引文献52

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部